Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;103:3086-3091

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Engström, G.
Right arrow Articles by Janzon, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Engström, G.
Right arrow Articles by Janzon, L.
Related Collections
Right arrow Pulmonary circulation and disease
Right arrow Arrhythmias, clinical electrophysiology, drugs
Right arrow Epidemiology

(Circulation. 2001;103:3086.)
© 2001 American Heart Association, Inc.


Clinical Investigation and Reports

Occurrence and Prognostic Significance of Ventricular Arrhythmia Is Related to Pulmonary Function

A Study From "Men Born in 1914," Malmö, Sweden

Gunnar Engström, MD, PhD; Per Wollmer, MD, PhD; Bo Hedblad, MD, PhD; Steen Juul-Möller, MD, PhD; Sven Valind, MD, PhD; Lars Janzon, MD, PhD

From the Departments of Community Medicine (G.E., B.H., L.J.), Clinical Physiology (P.W., S.V.), and Cardiology (S.J.-M.), Malmö University Hospital, Malmö, Sweden.

Correspondence to Dr. Gunnar Engström, Department of Community Medicine, Malmö University Hospital, S-20502 Malmö, Sweden. E-mail Gunnar.Engstrom{at}smi.mas.lu.se

Background—Reduced lung function has been associated with increased rates of myocardial infarction. Whether the occurrence and prognostic significance of ventricular arrhythmia is related to lung function is largely unknown.

Methods and Results—We performed a population-based study of 68-year-old men without a history of stroke or myocardial infarction; 402 men participated. Mortality and coronary events (fatal or nonfatal) were studied in relation to ventricular arrhythmia during 24 hours, percentage of the predicted forced expiratory volume (FEV1%pred), vital capacity (VC%pred), and the FEV/VC ratio. During 14 years of follow-up, 181 men died and 87 experienced a coronary event. Occurrence of frequent or complex ventricular arrhythmia (Lown class 2 to 5) was significantly and inversely associated with FEV1%pred. Men with Lown class 2 to 5 and a low FEV1%pred (below median) had significantly higher mortality (71.5 versus 26.8 per 1000 person-years; P<0.0001) and coronary event rates (37.7 versus 18.0; P=0.02) than men with Lown class 2 to 5 and a high FEV1%pred. These associations remained significant after adjustments for potential confounders (mortality: relative risk [RR], 2.91; 95% CI,1.68 to 5.04; coronary events: RR, 2.16; 95% CI, 1.07 to 4.37). In men without frequent or complex arrhythmia (Lown 0 to 1), a low FEV1%pred was not significantly associated with mortality (RR, 1.37; 95% CI, 0.92 to 2.05) or coronary events (RR, 1.24; 95% CI, 0.67 to 2.27) after adjustments for confounders. The FEV/VC ratio showed similar associations with arrhythmia, mortality, and coronary events.

Conclusions—Lung function is inversely associated with the occurrence of ventricular arrhythmia. The increased incidence of myocardial infarction and death associated with arrhythmia was mainly limited to men with a low FEV1%pred or FEV/VC. We suggest that lung function should be considered when assessing the prognostic significance of ventricular arrhythmia.


Key Words: electrocardiography • arrhythmia • lung • ventilation




This article has been cited by other articles:


Home page
ChestHome page
G. Engstrom, M. Gerhardsson de Verdier, M. Dahlback, C. Janson, and L. Lind
BP Variability and Cardiovascular Autonomic Function in Relation to Forced Expiratory Volume: A Population-Based Study
Chest, July 1, 2009; 136(1): 177 - 183.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
C. E Bolton, J. R Cockcroft, R. Sabit, M. Munnery, C. M McEniery, I. B Wilkinson, S. Ebrahim, J. E Gallacher, D. J Shale, and Y. Ben-Shlomo
Lung function in mid-life compared with later life is a stronger predictor of arterial stiffness in men: The Caerphilly Prospective Study
Int. J. Epidemiol., June 1, 2009; 38(3): 867 - 876.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
M. Gerhardsson de Verdier
The Big Three Concept: A Way to Tackle the Health Care Crisis?
Proceedings of the ATS, December 1, 2008; 5(8): 800 - 805.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. K. Han, V. V. McLaughlin, G. J. Criner, and F. J. Martinez
Pulmonary Diseases and the Heart
Circulation, December 18, 2007; 116(25): 2992 - 3005.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. Sabit and D. J. Shale
Vascular Structure and Function in Chronic Obstructive Pulmonary Disease: A Chicken and Egg Issue?
Am. J. Respir. Crit. Care Med., December 15, 2007; 176(12): 1175 - 1176.
[Full Text] [PDF]


Home page
Ther Adv Respir DisHome page
J. Tkac, S. F. P. Man, and D. D. Sin
Review: Systemic consequences of COPD
Therapeutic Advances in Respiratory Disease, October 1, 2007; 1(1): 47 - 59.
[Abstract] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. Sabit, C. E. Bolton, P. H. Edwards, R. J. Pettit, W. D. Evans, C. M. McEniery, I. B. Wilkinson, J. R. Cockcroft, and D. J. Shale
Arterial Stiffness and Osteoporosis in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1259 - 1265.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
S F P Man, J E Connett, N R Anthonisen, R A Wise, D P Tashkin, and D D Sin
C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease
Thorax, October 1, 2006; 61(10): 849 - 853.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
D. D. Sin and S. F. P. Man
Pharmacotherapy for Mortality Reduction in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, September 1, 2006; 3(7): 624 - 629.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
D. M. Mannino, G. Watt, D. Hole, C. Gillis, C. Hart, A. McConnachie, G. Davey Smith, M. Upton, V. Hawthorne, D. D. Sin, et al.
The natural history of chronic obstructive pulmonary disease.
Eur. Respir. J., March 1, 2006; 27(3): 627 - 643.
[Full Text] [PDF]


Home page
ChestHome page
D. D. Sin, L. Wu, and S. F. P. Man
The Relationship Between Reduced Lung Function and Cardiovascular Mortality: A Population-Based Study and a Systematic Review of the Literature
Chest, June 1, 2005; 127(6): 1952 - 1959.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Nemmar, B. Nemery, P. H. M. Hoet, N. Van Rooijen, and M. F. Hoylaerts
Silica Particles Enhance Peripheral Thrombosis: Key Role of Lung Macrophage-Neutrophil Cross-Talk
Am. J. Respir. Crit. Care Med., April 15, 2005; 171(8): 872 - 879.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
D. D. Sin and S. F. P. Man
Can inhaled steroids mend a broken heart in chronic obstructive pulmonary disease?
Eur. Respir. J., April 1, 2005; 25(4): 589 - 590.
[Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
D. D. Sin and S. F. P. Man
Chronic Obstructive Pulmonary Disease as a Risk Factor for Cardiovascular Morbidity and Mortality
Proceedings of the ATS, April 1, 2005; 2(1): 8 - 11.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
S. F. van Eeden, A. Yeung, K. Quinlam, and J. C. Hogg
Systemic Response to Ambient Particulate Matter: Relevance to Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, April 1, 2005; 2(1): 61 - 67.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
W. Q. Gan, S.F. P. Man, and D. D. Sin
The Interactions Between Cigarette Smoking and Reduced Lung Function on Systemic Inflammation
Chest, February 1, 2005; 127(2): 558 - 564.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
J van der Palen, T D Rea, T A Manolio, T Lumley, A B Newman, R P Tracy, P L Enright, and B M Psaty
Respiratory muscle strength and the risk of incident cardiovascular events
Thorax, December 1, 2004; 59(12): 1063 - 1067.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M T Kearney, K A A Fox, A J Lee, W P Brooksby, A M Shah, A Flapan, R J Prescott, R Andrews, P D Batin, D L Eckberg, et al.
Predicting sudden death in patients with mild to moderate chronic heart failure
Heart, October 1, 2004; 90(10): 1137 - 1143.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. D. Sin, P. Lacy, E. York, and S. F. P. Man
Effects of Fluticasone on Systemic Markers of Inflammation in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., October 1, 2004; 170(7): 760 - 765.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
D. D. Sin, F. A. McAlister, S. F. P. Man, and N. R. Anthonisen
Contemporary Management of Chronic Obstructive Pulmonary Disease: Scientific Review
JAMA, November 5, 2003; 290(17): 2301 - 2312.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
D D Sin and S F P Man
Impaired lung function and serum leptin in men and women with normal body weight: a population based study
Thorax, August 1, 2003; 58(8): 695 - 698.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Engstrom, P. Lind, B. Hedblad, P. Wollmer, L. Stavenow, L. Janzon, and F. Lindgarde
Lung Function and Cardiovascular Risk: Relationship With Inflammation-Sensitive Plasma Proteins
Circulation, November 12, 2002; 106(20): 2555 - 2560.
[Abstract] [Full Text] [PDF]